Cancer Research UK scientists have developed a technique they believe could be used to detect tiny secondary tumours in the brain, a process that is currently impossible, according to research published in PNAS.
28 March, 2012
In silico models, a phrase used to express ‘modelling performed on computer or via computer simulation’, is an area of very active development and has great potential across the pharmaceutical industry and also in other industries, such as the consumer goods and chemical industries, where ‘non-animal alternatives’ are being actively sought for assuring the safety of chemicals.
22 March, 2012
Proteome Sciences plc (“Proteome Sciences”) announces that Euro-HYP-1, a consortium of leading academic, clinical and industrial European partners in which it is a member, has been awarded a near €11m grant under the EU Framework 7 programme for new ground breaking research on the treatment of stroke.
19 March, 2012
An ancient Incan toothache remedy – for centuries handed down among an indigenous people in the rainforests of Peru – could be on the cusp of revolutionising worldwide dental practice.
14 March, 2012
As Brain Awareness Week (12–18 March) gets underway in the UK, the preliminary findings from the latest tinnitus research suggest that hearing aids might help tinnitus sufferers; research is ongoing into the role the brain has, and how tinnitus symptoms are reflected in brain network activity.
13 March, 2012
The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.
07 March, 2012
Cancer Research UK and its commercial arm, Cancer Research Technology have developed a unique test to discover molecules that could lead to potential new treatments for oestrogen receptor (ER)-positive breast cancer.
06 March, 2012
The University of Dundee has received over £10 million from the Wellcome Trust in the fight against some of the world’s most neglected parasitic diseases, including support for a multi-million pound partnership with GlaxoSmithKline (GSK) to discover new drug treatments.
06 March, 2012
When the FGF20 gene was ‘knocked out’ of mice, the animals appeared perfectly healthy but had absolutely no ability to hear. This single gene might provide important clues to the causes of some types of deafness. In humans, the gene has already been associated with inherited deafness in otherwise healthy families. This research was reported recently in an online scientific journal  and picked up by the national media.
01 March, 2012